Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37671079> ?p ?o ?g. }

Showing items 1 to 100 of ±108 with 100 items per page.

Q37671079 description "article científic" @default.
Q37671079 description "article scientifique" @default.
Q37671079 description "articolo scientifico" @default.
Q37671079 description "artigo científico" @default.
Q37671079 description "artículu científicu espublizáu en 2010" @default.
Q37671079 description "bilimsel makale" @default.
Q37671079 description "scientific article published on 08 January 2010" @default.
Q37671079 description "vedecký článok" @default.
Q37671079 description "vetenskaplig artikel" @default.
Q37671079 description "videnskabelig artikel" @default.
Q37671079 description "vědecký článek" @default.
Q37671079 description "wetenschappelijk artikel" @default.
Q37671079 description "wissenschaftlicher Artikel" @default.
Q37671079 description "наукова стаття, опублікована в січні 2010" @default.
Q37671079 description "научни чланак" @default.
Q37671079 description "مقالة علمية نشرت في 08 يناير 2010" @default.
Q37671079 name "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 name "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 name "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 type Item @default.
Q37671079 label "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 label "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 label "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 prefLabel "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 prefLabel "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 prefLabel "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 P1433 Q37671079-B1B79A77-EDEC-4AC9-AFB3-26196E08096C @default.
Q37671079 P1476 Q37671079-8878CFA3-0316-44B7-B9E4-D0437DE9F979 @default.
Q37671079 P2093 Q37671079-05238E6E-5DEB-4F0E-B1C7-A51D7279FAEC @default.
Q37671079 P2093 Q37671079-089DB415-9540-4A75-978D-F4F769128760 @default.
Q37671079 P2093 Q37671079-2329C8C2-20CA-4542-BF82-8BF731D269AB @default.
Q37671079 P2093 Q37671079-30D00D8E-B157-4FCA-A81A-2BAB07784800 @default.
Q37671079 P2093 Q37671079-4B7DB8EF-1E09-4629-A48D-189AB882010D @default.
Q37671079 P2093 Q37671079-50D26F9E-0B40-40A4-90B3-F06681951AC2 @default.
Q37671079 P2093 Q37671079-52782CFB-30EA-467F-BA1B-4DC9F6FFB1D0 @default.
Q37671079 P2093 Q37671079-73F64542-DB35-427B-8BEA-6480580D0CEB @default.
Q37671079 P2093 Q37671079-89449A6F-733B-4D2B-9172-2560D06DD3EA @default.
Q37671079 P2093 Q37671079-9C6146FB-9AAF-4B79-AD4B-60689780417B @default.
Q37671079 P2860 Q37671079-321B751B-3E1F-44E9-BD61-496519F5D796 @default.
Q37671079 P2860 Q37671079-36341482-A6B7-473B-B04B-239B3F7E60BF @default.
Q37671079 P2860 Q37671079-4525A813-BC92-4C06-8E1B-490424B0381F @default.
Q37671079 P2860 Q37671079-5C42CB57-8DED-46EC-9CB5-2B56132D71F7 @default.
Q37671079 P2860 Q37671079-5C9AC01E-7CD4-4860-9973-4EB4792A5D7E @default.
Q37671079 P2860 Q37671079-7957F01F-A6E8-4BB0-96E8-C7ED8505398E @default.
Q37671079 P2860 Q37671079-79AEE15D-D183-4343-918A-444667F34330 @default.
Q37671079 P2860 Q37671079-9EDCF9AD-49C9-408A-A141-4CE65EB0BDBD @default.
Q37671079 P2860 Q37671079-9F513164-574D-4F14-A3BE-0112BEB0C6FF @default.
Q37671079 P2860 Q37671079-A9403C34-A641-4914-8882-317CF87A2890 @default.
Q37671079 P2860 Q37671079-B0E2C9E4-2E27-4380-AEBF-EDF879CA0F7B @default.
Q37671079 P2860 Q37671079-B72BEBF8-E833-4BC6-9117-6A157D691CAB @default.
Q37671079 P2860 Q37671079-CEC5CC93-04EF-41FC-9B90-76EDD4F3FFC8 @default.
Q37671079 P2860 Q37671079-D0084753-259C-4E27-8820-734CE7A06EA2 @default.
Q37671079 P2860 Q37671079-DC56BF2B-D6DA-4A6F-8BC1-6F04007B4473 @default.
Q37671079 P2860 Q37671079-DD5C87AC-A44B-4AE7-AC2B-BE05DA670500 @default.
Q37671079 P2860 Q37671079-DFA40031-5EAA-4AAC-9DEB-E8AAA9212117 @default.
Q37671079 P2860 Q37671079-F7BE710A-3A7B-472E-AE5F-434E8EA7503C @default.
Q37671079 P304 Q37671079-2F1C43FE-0AF3-43F8-8562-CF63275A2551 @default.
Q37671079 P31 Q37671079-E7272F2B-EB85-4716-AFA4-57672E86FDAD @default.
Q37671079 P356 Q37671079-E737A65E-1DB2-46E6-B92E-59589C54E0D3 @default.
Q37671079 P407 Q37671079-60A4C4D3-AFF9-4C48-8B57-63F797191BBE @default.
Q37671079 P433 Q37671079-7CEF75DF-B139-4055-BFE8-81067553B509 @default.
Q37671079 P478 Q37671079-33048AD2-465C-420F-A6E7-34FD940A3577 @default.
Q37671079 P50 Q37671079-7E39BECF-5D74-4C77-AAA4-108903D1AB08 @default.
Q37671079 P577 Q37671079-832D1D04-E180-4379-8A38-FA31BEC1571B @default.
Q37671079 P698 Q37671079-C3E4C4FC-30D3-4242-B92B-8E93CE0DC3E4 @default.
Q37671079 P921 Q37671079-8CF9ACC9-FBED-4456-858D-964E2970F1C3 @default.
Q37671079 P356 J.YGYNO.2009.12.010 @default.
Q37671079 P698 20060158 @default.
Q37671079 P1433 Q5625182 @default.
Q37671079 P1476 "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor" @default.
Q37671079 P2093 "Annerie Slot" @default.
Q37671079 P2093 "Astrid Scholten" @default.
Q37671079 P2093 "Eltjo M J Schutter" @default.
Q37671079 P2093 "Elzbieta M van der Steen-Banasik" @default.
Q37671079 P2093 "Jan J Jobsen" @default.
Q37671079 P2093 "Job van der Palen" @default.
Q37671079 P2093 "Lambert Naudin ten Cate" @default.
Q37671079 P2093 "Marika C Stenfert Kroese" @default.
Q37671079 P2093 "Marnix L M Lybeert" @default.
Q37671079 P2093 "Sabine Siesling" @default.
Q37671079 P2860 Q28216788 @default.
Q37671079 P2860 Q33180279 @default.
Q37671079 P2860 Q33672471 @default.
Q37671079 P2860 Q36524639 @default.
Q37671079 P2860 Q36626142 @default.
Q37671079 P2860 Q36648691 @default.
Q37671079 P2860 Q37032842 @default.
Q37671079 P2860 Q40424321 @default.
Q37671079 P2860 Q40905856 @default.
Q37671079 P2860 Q46009244 @default.
Q37671079 P2860 Q68011916 @default.
Q37671079 P2860 Q68990284 @default.
Q37671079 P2860 Q71132855 @default.
Q37671079 P2860 Q71738738 @default.
Q37671079 P2860 Q73516925 @default.
Q37671079 P2860 Q74342936 @default.
Q37671079 P2860 Q74448998 @default.
Q37671079 P2860 Q74753108 @default.
Q37671079 P304 "32-36" @default.
Q37671079 P31 Q13442814 @default.